A Study Assessing Use of Regorafenib In The Real-Life Clinical Practice: Data From The Czech Registry.
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2016
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Oct 2016 New trial record
- 14 Sep 2016 Results published in the Targeted Oncology Journal.